Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
BMC Pregnancy Childbirth ; 19(1): 240, 2019 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-31296180

RESUMEN

BACKGROUND: Ragged placental membranes is a distinct entity from retained placenta and not uncommonly reported in midwifery texts. Although the incidence of postpartum endometritis is merely 1-5% after vaginal births, it remains the most common source of puerperal sepsis, contributing up to 15% of maternal mortality in low income countries. Geographically-remote centres in Malaysia prophylactically administer antibiotics for women with ragged placental membranes after vaginal birth, extrapolating evidence from retained placenta. We sought to clarify the rationale in continuing such practices. METHODS: This was an open-label, prospective, multicentre, randomized trial. Three hospitals where the current protocol was to administer prophylactic amoxycillin-clavulanic acid served as the sites of recruitment. Women who delivered vaginally beyond 24+ 0 weeks of gestation with ragged membranes were invited to participate in the trial and randomized into prophylaxis or expectant management with medical advice by blocks of 10, at a 1:1 ratio. A medication adherence diary was provided and patients followed up at 2 weeks and 6 weeks postpartum. RESULTS: A total of 6569 women gave birth vaginally in three centres during the trial period, of which 10.9% had ragged membranes. The incidence of endometritis was not significantly raised in women with or without prophylaxis (0.90% vs 0.29%; p = 0.60). All cases of endometritis presented within the first 2 weeks and preventive use of antibiotics did not ameliorate the severity of endometritis since rates of ICU admission, surgical evacuation and transfusion were comparable. CONCLUSION: Preventive use of antibiotics after vaginal delivery in women with ragged placental membranes did not result in a reduction of endometritis. Educating women on the signs and symptoms of endometritis would suffice. Based on the reported incidence of ragged membranes, a change in practice would result in 1500 less prescriptions of antibiotics per annum in these three centres. TRIAL REGISTRATION: NCT03459599 (Retrospectively registered on 9 March 2018).


Asunto(s)
Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Antibacterianos/administración & dosificación , Profilaxis Antibiótica/métodos , Endometritis/prevención & control , Retención de la Placenta/tratamiento farmacológico , Trastornos Puerperales/prevención & control , Adulto , Parto Obstétrico , Femenino , Humanos , Malasia , Periodo Posparto , Embarazo , Estudios Prospectivos , Resultado del Tratamiento , Vagina
2.
Fetal Diagn Ther ; 46(5): 285-295, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30861511

RESUMEN

BACKGROUND: Fetal subdural haematoma (SDH) is associated with poor prognosis. OBJECTIVE: The conflicting evidence from the literature presents a challenge in prenatal counselling. We present a case study and systematic review of the literature for the management and outcome of fetal SDH. METHODS: Systematic search of electronic database. RESULTS: A total 45 cases were extracted from 39 papers. Prenatal ultrasonographic features were intracranial echogenicity (42%), lateral ventriculomegaly (38%), presence of an intracranial mass (31%), macrocephaly (24%), midline deviation of cerebral falx (20%), and intracranial fluid collection (11%). Further secondary features were noted including reversed diastolic flow in the middle cerebral artery (11%), echogenic bowel (4%), hydrops fetalis (2%), and elevated middle cerebral artery peak systolic velocity (2%) (all highly likely to be associated with fetal anaemia). The rates of termination of pregnancy, stillbirth, and neonatal death were 18% (8/45), 16% (7/45), and 11% (5/45), respectively. Overall, therefore, the fetal and perinatal mortality was 32% (12/37). Amongst the 24 survivors with available neurological outcome, 42% (10/24) and 58% (14/24) had abnormal and normal neurological outcome, respectively. Underlying aetiology of fetal SDH was not identified in 47% (21/45). Fetal SDH with an identifiable underlying aetiology was the only factor associated with a higher chance of normal neurological outcome when compared to fetal SDH without a detectable cause (78.5 vs. 21.4%, p = 0.035). CONCLUSIONS: Stillbirth and neonatal death occurred in a significant proportion of fetal SDH. 58% of survivors had normal neurological outcome, and better prognosis was seen in SDH with identifiable underlying aetiology.


Asunto(s)
Rotura Prematura de Membranas Fetales/etiología , Hematoma Subdural/diagnóstico por imagen , Imagen por Resonancia Magnética , Trabajo de Parto Prematuro/etiología , Mortinato , Ultrasonografía Prenatal , Adulto , Resultado Fatal , Femenino , Edad Gestacional , Hematoma Subdural/etiología , Hematoma Subdural/terapia , Humanos , Valor Predictivo de las Pruebas , Embarazo , Factores de Riesgo
4.
Fetal Diagn Ther ; 45(5): 285-294, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30554214

RESUMEN

BACKGROUND/PURPOSE: We report a case study of jejunal atresia and the results of a systematic literature review of all reported cases of bowel complications occurring after fetoscopic laser ablation (FLA) for the treatment of twin-to-twin transfusion syndrome (TTTS). METHODS: A systematic literature review was performed of bowel complications after FLA for TTTS according to PRISMA guidelines. RESULTS: There are 11 published cases of small bowel atresia, 5 cases of necrotising enterocolitis (NEC), and 2 cases with foetal bowel perforations. Recipient twins were more likely to be affected by small bowel atresia (7 recipient and 4 donor cases) and NEC (3 recipient and 2 donor twins). Prenatal ultrasonographic abnormalities were demonstrated in 7 out of 9 cases with bowel atresia and in both cases of bowel perforation. The overall survival rate for neonates with bowel complications after FLA is 72%, but is much lower for co-twins at 22%. The survival rates for jejunoileal atresia and NEC are 91 and 40%, respectively. CONCLUSIONS: It is uncertain as to whether these bowel anomalies are due to bowel ischaemia associated with TTTS, the treatment with FLA, or a combination of both. Cases with prenatal abdominal ultrasonographic abnormalities after FLA should have close prenatal and postnatal assessment to detect bowel complications.


Asunto(s)
Anemia/diagnóstico por imagen , Ascitis/diagnóstico por imagen , Transfusión Feto-Fetal/diagnóstico por imagen , Fetoscopía/métodos , Atresia Intestinal/diagnóstico por imagen , Terapia por Láser/métodos , Adulto , Anemia/cirugía , Ascitis/cirugía , Corion/diagnóstico por imagen , Corion/cirugía , Femenino , Muerte Fetal , Transfusión Feto-Fetal/cirugía , Fetoscopía/efectos adversos , Humanos , Recién Nacido , Atresia Intestinal/cirugía , Terapia por Láser/efectos adversos , Embarazo , Embarazo Gemelar , Recurrencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA